TIDMMDC
RNS Number : 1759S
Mediclinic International plc
21 June 2018
Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
South African income tax number: 9950122714
("Mediclinic", the "Company" or the "Group")
21 June 2018
TAX TREATMENT OF ORDINARY SHARE DIVIDEND FOR SHAREHOLDERS ON THE
SOUTH AFRICAN REGISTER
Background
Shareholders on the South African register of the Company are
referred to Mediclinic's announcement of the results for the year
ended 31 March 2018 and proposed dividend announcement released on
the Stock Exchange News Service and on the Regulatory News Service
on 24 May 2018, confirming that the Board of Directors of
Mediclinic had proposed a final dividend from retained earnings of
4.70 pence per ordinary share for the year ended 31 March 2018 for
approval by the Company's shareholders at the annual general
meeting on Wednesday, 25 July 2018.
The final dividend will be paid on Monday, 30 July 2018 to all
ordinary shareholders who are on the register of members at the
close of business on the record date of Friday, 15 June 2018.
Shareholders on the South African register will be paid the ZAR
cash equivalent of 79.52400 cents (63.61920 cents net of dividend
withholding tax) per share. A dividend withholding tax of 20% will
be applicable to all shareholders on the South African register who
are not exempt therefrom. The ZAR cash equivalent has been
calculated using the following exchange rate: GBP1: ZAR16.92, being
the 5-day average ZAR/GBP exchange rate (Bloomberg) on Friday, 18
May 2018 at 3:00pm GMT.
Tax treatment for shareholders on the South African register
South African tax resident shareholders on the South African
register:
In terms of the Company's Dividend Access Trust structure,
eligible South African tax resident shareholders on the South
African register set out below will receive the full dividend,
namely 79.52400 cents per share, from the Dividend Access Trust and
therefore regarded as a local South African dividend. For purposes
of South African dividend withholding tax, the entire dividend of
79.52400 cents per share is taxable at a rate of 20%, unless an
applicable exemption applies:
1. in the case of shares held in certificated form, eligible
shareholders who are registered on the South African
register with an address in South Africa (other than
PLC Nominees Proprietary Limited (or any successor
entity through which shares held in dematerialised
form are held)); and
2. in the case of shares held in dematerialised form,
in respect of whom the South African transfer secretaries
of the Company have determined, in good faith and by
reference to the information provided to them by the
eligible shareholders and/or their brokers and/or central
securities depository participants, that such eligible
shareholders are either (i) tax resident in South Africa
or (ii) have an address in South Africa and have not
expressly indicated that they are not tax resident
in South Africa as at the dividend record date.
Non-South African tax resident shareholders on the South African
register:
Non-South African tax resident shareholders on the South African
register will be paid the dividend by the Company in the usual way
and not through the Dividend Access Trust. The entire dividend of
79.52400 cents per share payable to such shareholders will
therefore be regarded as a foreign dividend and exempt from South
African dividend withholding tax, provided that the relevant
exemption forms have been completed and submitted as
prescribed.
About Mediclinic International plc
Mediclinic is an international private healthcare services group
with operating divisions in Switzerland, Southern Africa (South
Africa and Namibia) and the United Arab Emirates. Its core purpose
is to enhance the quality of life of patients by providing acute
care, specialist-orientated, multi-disciplinary healthcare
services. Mediclinic also holds a 29.9% interest in Spire
Healthcare Group plc, an LSE-listed and UK-based private healthcare
group.
Mediclinic comprises 75 hospitals and 28 clinics. Hirslanden
operates 17 private acute care facilities and 4 clinics in
Switzerland with more than 1 800 inpatient beds; Mediclinic
Southern Africa operates 49 hospitals and 2 day clinics throughout
South Africa and 3 hospitals in Namibia with more than 8 100
inpatient beds in total; and Mediclinic Middle East operates 6
hospitals and 22 clinics with more than 700 inpatient beds in the
United Arab Emirates.
Mediclinic has a primary listing on the Main Market of the LSE
in the United Kingdom, with secondary listings on the JSE in South
Africa and the NSX in Namibia.
For further information, please contact:
Company Secretary, Link Company Matters Limited
Jayne Meacham / Caroline Emmet
+44 (0)20 7954 9569
Investor Relations, Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
+44 (0)20 3786 8181
Media queries
FTI Consulting
Brett Pollard/Debbie Scott - UK
+44 (0)20 3727 1000
Sherryn Schooling - South Africa
+27 (0)21 487 9000
Registered address: 6(th) Floor, 65 Gresham Street, London, EC2V
7NQ, United Kingdom
Website: www.mediclinic.com
Joint corporate brokers: Morgan Stanley & Co International
plc and UBS Investment Bank
JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank
Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
MSCUAVURWBANUAR
(END) Dow Jones Newswires
June 21, 2018 09:30 ET (13:30 GMT)
Mediclinic (LSE:MDC)
Historical Stock Chart
From Apr 2024 to May 2024
Mediclinic (LSE:MDC)
Historical Stock Chart
From May 2023 to May 2024